Natco Pharma decided to sales its US based pharmacy store. Natco decided in thier board meeting to sale of its Save Mart Store in the USA.
Pharma News
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
-
-
Natco Pharma Limited notified that an inspection was conducted by the United States Food & Drug Administration (USFDA) in two of its manufacturing facilities.
-
Adaptimmune Therapeutics plc announced that the U.S. Food and Drug Administration (FDA)'s Office of Orphan Products Development has granted orphan drug designation for the company’s affinity enhanced T-cell therapy targeting NY-ESO for the treatment of soft tissue sarcoma, a solid tumor cancer.
-
A drug used in the treatment of diabetes can increase the risk of bladder cancer, warns a new study adding that the risk increases with the rising duration of use and the dose.
-
The rising cost of raw materials, stringent regulatory requirements and increasingly competitive environment all are rapidly eroding the profit margins of many antibiotic manufacturers. BCC Research reveals in its new report that these challenges, and the growing problem of antibiotic resistance, have dramatically shifted the business models of some of the industry’s leading pharmaceutical companies.
-
Opening the door for new detection method that could allow doctors to diagnose patients with certain cancers far earlier than possible today, researchers have developed an optical sensor that they claim is one million times more sensitive than the current best available.
-
In a major advance towards a universal flu jab which would protect people against all strains of the virus, researchers have developed a new vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.
-
Using a nanoparticle that delivers a drug and then glows green when cancer cells begin dying, Indian origin researchers have found a way to detect the effectiveness of cancer treatment much sooner than currently available clinical methods.
-
Sun Pharma acquired established prescription brands from Novartis AG and Novartis Pharma AG (together Novartis) in Japan. In a USD 293 million cash deal Indias Sun Pharmaceutical Industries Ltd. has agreed to buy 14 established prescription brands from Novartis AG and Novartis Pharma AG in Japan, the Indian company said.
In a statement issued late Tuesday the company said that a wholly-owned subsidiary of Sun Pharma will acquire the portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of USD 293 million.
"These brands have combined annualised revenues of approximately USD 160 million and address medical conditions across several therapeutic areas," the company said.
"Under the terms of the agreements, Novartis will continue to distribute these brands, for a certain period, pending transfer of all marketing authorisations to Sun Pharma's subsidiary."
The acquired brands will be marketed by a reliable and established local marketing partner under the Sun Pharma label. The partner will also be responsible for distribution of the brands.
Commenting on the acquisition, Dilip Shanghvi, Managing Director, Sun Pharma said, “Japan is a market of strategic interest for us. This acquisition marks Sun Pharma’s foray into the Japanese prescription market and provides us an opportunity to build a larger product portfolio in the future.”
As per the December-2015 IMS Data, the size of the Japanese pharmaceutical market was estimated at USD 73 billion, accounting for over seven percent of the USD 1 trillion global pharmaceutical market.
-
In an effort to slash high costs, provide customised treatment and improve diagnostic tests, doctors, engineers and researchers from several premiere institutions in the country have created a common platform to intensify research on nanotechnology a promising method for precise treatment.
RECOMMENDED POSTS
Subscribe with us
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
